Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minghui Duan

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
European Radiology|September 23, 2020
Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myelomaLu Zhang, Qin Wang, Xia Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 27, 2014
[The prevalence of Acinetobacter baumannii in hematology ward of single center from 2010 to 2012]Lu Wang, Qian Zhang, Bing Han, et al.
Cancer Medicine|July 3, 2025
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2<sup>V617F</sup>-Positive Myeloproliferative NeoplasmsGuangshuai Teng, Ke Shang, Yuhui Zhang, et al.
Annals of Hematology|October 30, 2018
Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from ChinaShaoxuan Hu, Daobin Zhou, Yongji Wu, et al.
British Journal of Haematology|December 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathologyRong Wang, Zhongxun Shi, Yuan Zhang, et al.
Blood Advances|October 31, 2025
Long-term Efficacy and Safety of Ropeginterferon Alfa-2b under its HIDAT Regimen for the Treatment of Polycythemia VeraShanshan Suo, Rongfeng Feng Fu, Albert Qin, et al.
British Journal of Haematology|October 27, 2024
Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2bShanshan Suo, Rong Feng Fu, Albert Qin, et al.
Haematologica|June 27, 2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemiaYunfan Yang, Yuntao Liu, Hui Sun, et al.
Nature Communications|April 6, 2023
Author Correction: High-performance Marangoni hydrogel rotors with asymmetric porosity and drag reduction profileHao Wu, Yiyu Chen, Wenlong Xu, et al.
Nature Communications|January 3, 2023
High-performance Marangoni hydrogel rotors with asymmetric porosity and drag reduction profileHao Wu, Yiyu Chen, Wenlong Xu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
European Radiology|September 23, 2020
Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myelomaLu Zhang, Qin Wang, Xia Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 27, 2014
[The prevalence of Acinetobacter baumannii in hematology ward of single center from 2010 to 2012]Lu Wang, Qian Zhang, Bing Han, et al.
Cancer Medicine|July 3, 2025
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2<sup>V617F</sup>-Positive Myeloproliferative NeoplasmsGuangshuai Teng, Ke Shang, Yuhui Zhang, et al.
Annals of Hematology|October 30, 2018
Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from ChinaShaoxuan Hu, Daobin Zhou, Yongji Wu, et al.
British Journal of Haematology|December 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathologyRong Wang, Zhongxun Shi, Yuan Zhang, et al.
Blood Advances|October 31, 2025
Long-term Efficacy and Safety of Ropeginterferon Alfa-2b under its HIDAT Regimen for the Treatment of Polycythemia VeraShanshan Suo, Rongfeng Feng Fu, Albert Qin, et al.
British Journal of Haematology|October 27, 2024
Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2bShanshan Suo, Rong Feng Fu, Albert Qin, et al.
Haematologica|June 27, 2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemiaYunfan Yang, Yuntao Liu, Hui Sun, et al.
Nature Communications|April 6, 2023
Author Correction: High-performance Marangoni hydrogel rotors with asymmetric porosity and drag reduction profileHao Wu, Yiyu Chen, Wenlong Xu, et al.
Nature Communications|January 3, 2023
High-performance Marangoni hydrogel rotors with asymmetric porosity and drag reduction profileHao Wu, Yiyu Chen, Wenlong Xu, et al.
Pageof 7